tiprankstipranks
SOL SPA (IT:SOL)
:SOL
Want to see IT:SOL full AI Analyst Report?

SOL SPA (SOL) Price & Analysis

16 Followers

SOL Stock Chart & Stats

€62.90
-€0.70(-1.11%)
At close: 4:00 PM EDT
€62.90
-€0.70(-1.11%)

Bulls Say, Bears Say

Bulls Say
Consistent Revenue GrowthSustained annual revenue growth indicates resilient demand and expanding market reach. The 2025 re-acceleration provides a durable base for continued earnings growth over the next several quarters.
Stable Operating MarginsStable mid-teens EBIT margins and strong EBITDA margins demonstrate solid operating economics. This profitability profile can support reinvestment and earnings resilience despite industry cost pressures.
Healthy Returns And Reasonable LeverageHistorically moderate leverage and consistently healthy returns on equity indicate an established operating model with reasonable capital efficiency. These characteristics support financial resilience, despite the recent increase in debt.
Bears Say
Declining Free Cash FlowFalling free cash flow limits financial flexibility and weakens the quality of reported earnings. Continued capital spending or inefficient cash conversion could constrain debt reduction, investment capacity, and shareholder returns.
Higher 2025 LeverageThe upward leverage trend reduces balance-sheet flexibility and increases sensitivity to higher financing costs or weaker earnings. If sustained, additional debt could limit investment options and make cash-flow weakness more consequential.
Gross Margin VolatilityVolatile gross margins may reflect changing input costs, pricing power, or product mix. This variability creates earnings-quality risk and could eventually pressure EBIT margins if operating stability does not offset gross-profit fluctuations.

SOL FAQ

What was SOL SPA’s price range in the past 12 months?
SOL SPA lowest stock price was €44.85 and its highest was €64.00 in the past 12 months.
    What is SOL SPA’s market cap?
    SOL SPA’s market cap is €4.79B.
      When is SOL SPA’s upcoming earnings report date?
      SOL SPA’s upcoming earnings report date is Sep 03, 2026 which is in 11 days.
        How were SOL SPA’s earnings last quarter?
        SOL SPA released its earnings results on Mar 26, 2026. The company reported €0.92 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is SOL SPA overvalued?
          According to Wall Street analysts SOL SPA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does SOL SPA pay dividends?
            SOL SPA pays a Annually dividend of €0.45 which represents an annual dividend yield of 0.85%. See more information on SOL SPA dividends here
              What is SOL SPA’s EPS estimate?
              SOL SPA’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does SOL SPA have?
              SOL SPA has 90,700,000 shares outstanding.
                What happened to SOL SPA’s price movement after its last earnings report?
                SOL SPA reported an EPS of €0.92 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.04%.
                  Which hedge fund is a major shareholder of SOL SPA?
                  Currently, no hedge funds are holding shares in IT:SOL
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    SOL SPA

                    SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.

                    SOL SPA (SOL) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    A2A SpA
                    ACEA SPA
                    Edison Spa
                    Enel S.p.A.
                    HERA S.p.A.
                    Popular Stocks